Literature DB >> 22773150

Correlation between serum 25-hydroxyvitamin D concentrations and regional cerebral blood flow in degenerative dementia.

Karim Farid1, Lisette Volpe-Gillot, Slavomir Petras, Caroline Plou, Nadine Caillat-Vigneron, Jacques Blacher.   

Abstract

BACKGROUND: Chronic low serum vitamin D concentrations are common among the elderly. Recent studies have suggested that its metabolite, 25-hydroxyvitamin D (25-OHD), might be important for preserving cognitive functions through specific brain protective effects. However, this hypothesis is still under discussion. The aim of this study was to assess the correlation between serum 25-OHD concentrations and regional cerebral blood flow in neurodegenerative diseases such as Alzheimer's disease (AD) and dementia of Lewy bodies (DLB). PATIENTS AND METHODS: Radionuclide brain single-photon emission computed tomography/computed tomography (SPECT/CT) images and 25-OHD dosage in noninstitutionalized patients were obtained within 14 days. SPECT/CT examination was carried out using technetium-99m-ethyl cysteinate dimer in 20 consecutive patients (12 AD and eight DLB). Reconstructed images were spatially normalized using Statistical Parametric Mapping version 5 software to a default SPECT template. Voxel-based multiple regression correlation analyses, with age and mini mental state examination scores as confounding factors, were carried out. Findings were considered significant for a threshold P-value less than 0.01 (corrected at cluster level).
RESULTS: A positive correlation was found between 25-OHD concentrations and regional cerebral blood flow in the left precuneus cortex (Talairach coordinates: -14, -42, 63) in AD patients. No correlation was detected in DLB patients.
CONCLUSION: The results of this study confirm the relationship between 25-OHD concentrations and AD and therefore underline the hypothesis of a potential neuroprotective effect against brain degeneration. These encouraging findings need to be confirmed by larger prospective correlation series.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22773150     DOI: 10.1097/MNM.0b013e32835674c4

Source DB:  PubMed          Journal:  Nucl Med Commun        ISSN: 0143-3636            Impact factor:   1.690


  8 in total

1.  The transcriptomic response of mixed neuron-glial cell cultures to 1,25-dihydroxyvitamin d3 includes genes limiting the progression of neurodegenerative diseases.

Authors:  Marie-France Nissou; Jacques Brocard; Michèle El Atifi; Audrey Guttin; Annie Andrieux; François Berger; Jean-Paul Issartel; Didier Wion
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

2.  Dietary vitamin D deficiency in rats from middle to old age leads to elevated tyrosine nitration and proteomics changes in levels of key proteins in brain: implications for low vitamin D-dependent age-related cognitive decline.

Authors:  Jeriel T R Keeney; Sarah Förster; Rukhsana Sultana; Lawrence D Brewer; Caitlin S Latimer; Jian Cai; Jon B Klein; Nada M Porter; D Allan Butterfield
Journal:  Free Radic Biol Med       Date:  2013-07-18       Impact factor: 7.376

3.  Vitamin D deficiency and its relationship with endothelial dysfunction in patients with early Parkinson's disease.

Authors:  Jung Han Yoon; Dong Kyu Park; Seok Woo Yong; Ji Man Hong
Journal:  J Neural Transm (Vienna)       Date:  2015-09-05       Impact factor: 3.575

4.  The vitamin D, ionised calcium and parathyroid hormone axis of cerebral capillary function: therapeutic considerations for vascular-based neurodegenerative disorders.

Authors:  Virginie Lam; Ryusuke Takechi; Menuka Pallabage-Gamarallage; Corey Giles; John C L Mamo
Journal:  PLoS One       Date:  2015-04-13       Impact factor: 3.240

5.  Vitamin D and Risk of Neuroimaging Abnormalities.

Authors:  Thomas J Littlejohns; Katarina Kos; William E Henley; Iain A Lang; Cedric Annweiler; Olivier Beauchet; Paulo H M Chaves; Bryan R Kestenbaum; Lewis H Kuller; Kenneth M Langa; Oscar L Lopez; David J Llewellyn
Journal:  PLoS One       Date:  2016-05-11       Impact factor: 3.240

6.  Circulatory 25(OH)D and 1,25(OH)2D as differential biomarkers between multiple system atrophy and Parkinson's disease patients.

Authors:  Hiromu Ogura; Izzettin Hatip-Al-Khatib; Midori Suenaga; Funda Bolukbasi Hatip; Takayasu Mishima; Shinsuke Fujioka; Shinji Ouma; Yoichi Matsunaga; Yoshio Tsuboi
Journal:  eNeurologicalSci       Date:  2021-09-23

7.  Serum vitamin D in patients with mild cognitive impairment and Alzheimer's disease.

Authors:  Shinji Ouma; Midori Suenaga; Funda F Bölükbaşı Hatip; Izzettin Hatip-Al-Khatib; Yoshio Tsuboi; Yoichi Matsunaga
Journal:  Brain Behav       Date:  2018-02-09       Impact factor: 2.708

8.  Vitamin D levels, brain volume, and genetic architecture in patients with psychosis.

Authors:  Akiah Ottesen Berg; Kjetil N Jørgensen; Mari Nerhus; Lavinia Athanasiu; Alice B Popejoy; Francesco Bettella; Linn Christin Bonaventure Norbom; Tiril P Gurholt; Sandra R Dahl; Ole A Andreassen; Srdjan Djurovic; Ingrid Agartz; Ingrid Melle
Journal:  PLoS One       Date:  2018-08-24       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.